Trial Profile
Staging with [18F]PSMA PET prior to Lymph node dissection in patients with prostatic Tumors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Aug 2020
Price :
$35
*
At a glance
- Drugs Piflufolastat F18 (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- Acronyms SALT
- 26 Jul 2020 Status changed from recruiting to completed.
- 26 Jul 2020 Results presented at the 35th Congress of the European Association of Urology
- 03 Dec 2018 New trial record